• $25.00

    Course with .5 hours of APA CE and NYSED CE for Psychologists, Social Workers, and LMHCs

    Get started now

Learning Objectives

At the end of this course, students will be able to:

  • Articulate the role of colonization in the formation of drug policy in the United States

  • Identify one way US Drug policy impacts psychedelic drug research

  • Define and delineate FDA breakthrough designation from other FDA designations

  • Identify the DEA scheduling status of psilocybin, MDMA, and ketamine

  • Identify where MDMA, psilocybin, and ketamine are in the process of approval for use in psychedelic-assisted therapy

  • Name at least one policy issue currently facing the field of psychedelic-assisted therapy

  • Identify at least 1 way to support the successful adoption of psychedelic therapies post FDA-approval

Instructor

Director of Policy and Regulatory Affairs

Victor Cabral, MSW, LSW, CCTP-I

Victor Cabral, MSW, LSW, CCTP-I (He/Him/His) is a collaborative and strategic leader who has made an impact on human rights and historical inequalities throughout his career. Before joining Fluence, Victor served as Deputy Director for the Pennsylvania Governor's Office of Advocacy and Reform where he helped lead the implementation of the Trauma-Informed PA Plan, establish the first Racial Day of Healing in Pennsylvania history, and developed free trauma trainings for Pennsylvanians in collaboration with internationally recognized experts. He is a research-based systems thinker with expertise in policy development, advocacy, consulting, racial and communal trauma, and is a practicing psychotherapist with training in Internal Family Systems, Psychedelic-Assisted Psychotherapy (MDMA and Ketamine), and other modalities. Victor was also listed on the Students for Sensible Drug Policy’s list of ’40 Under 40 Outstanding BIPOC Leaders in Drug Policy in the United States’ for his work in psychedelic policy.

Continuing Education

Included Continuing Education Credits with Certificate of Completion

  • Fluence International, Inc. is approved by the American Psychological Association to sponsor continuing education for psychologists. Fluence maintains responsibility for this program and its content.

  • Fluence International, Inc. is recognized by the New York State Education Department’s State Board for Mental Health Practitioners as an approved provider of continuing education for licensed mental health counselors. #MHC-0232.

  • Fluence International, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0674.

  • Fluence International, Inc. is recognized by the New York State Education Department's State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0167.

  • The Department’s approval of a provider of continuing education does not constitute the Department’s endorsement of the content, positions or practices that may be addressed in any specific continuing education course offered by the approved provider.

  • For questions about receiving your CE Certificate of Completion, contact Selah Drain, selah@fluencetraining.com.